Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
REVENUE	$ 7,650,269	$ 3,384,767
Cost of Revenue	3,080,116	2,112,035
GROSS PROFIT	4,570,153	1,272,732
EXPENSES
General and administrative expenses [Notes 8, 9,12,13]	19,845,939	12,565,396
Research and development expenses	2,744,587	2,059,130
TOTAL OPERATING EXPENSES	22,590,526	14,624,526
Other income [Note 3]	(15,120)	(36,636)
Loss upon convertible promissory notes conversion [Note 9]	1,155,642	103,735
Accretion and amortization expenses [Note 5,6]	9,286,023	2,481,155
Change in fair value of derivative liabilities [Note 8]	683,559	(408,872)
NET LOSS BEFORE INCOME TAXES	(29,130,477)	(15,491,176)
Income taxes [Note 10]
NET LOSS BEFORE DIVIDENDS	(29,130,477)	(15,491,176)
Less: Preferred Stock Dividends	1,088,977	962,148
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(30,219,454)	(16,453,324)
Translation adjustment	(134,470)	223,121
COMPREHENSIVE LOSS	$ (30,353,924)	$ (16,230,203)
LOSS PER SHARE, BASIC AND DILUTED	$ (0.665)	$ (0.438)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	45,449,720	37,522,978